[go: up one dir, main page]

NO20010064D0 - Midler med en antidepressiv virkning - Google Patents

Midler med en antidepressiv virkning

Info

Publication number
NO20010064D0
NO20010064D0 NO20010064A NO20010064A NO20010064D0 NO 20010064 D0 NO20010064 D0 NO 20010064D0 NO 20010064 A NO20010064 A NO 20010064A NO 20010064 A NO20010064 A NO 20010064A NO 20010064 D0 NO20010064 D0 NO 20010064D0
Authority
NO
Norway
Prior art keywords
drugs
antidepressant effect
antidepressant
effect
Prior art date
Application number
NO20010064A
Other languages
English (en)
Other versions
NO20010064L (no
Inventor
Jerzy Maj
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20010064D0 publication Critical patent/NO20010064D0/no
Publication of NO20010064L publication Critical patent/NO20010064L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20010064A 1998-07-07 2001-01-05 Midler med en antidepressiv virkning NO20010064L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830201A DE19830201A1 (de) 1998-07-07 1998-07-07 Mittel mit antidepressiver Wirkung
PCT/EP1999/004595 WO2000002542A2 (de) 1998-07-07 1999-07-02 Mittel mit antidepressiver wirkung, enthaltend pramipexol und ein weiteres antidepressivum

Publications (2)

Publication Number Publication Date
NO20010064D0 true NO20010064D0 (no) 2001-01-05
NO20010064L NO20010064L (no) 2001-03-02

Family

ID=7873155

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010064A NO20010064L (no) 1998-07-07 2001-01-05 Midler med en antidepressiv virkning

Country Status (32)

Country Link
US (1) US6255329B1 (no)
EP (1) EP1093369B1 (no)
JP (1) JP2002520273A (no)
KR (1) KR100557692B1 (no)
CN (1) CN1230168C (no)
AR (1) AR019896A1 (no)
AT (1) ATE228365T1 (no)
AU (1) AU762128B2 (no)
BG (1) BG64972B1 (no)
BR (1) BR9911768A (no)
CA (1) CA2336833C (no)
CZ (1) CZ294087B6 (no)
DE (2) DE19830201A1 (no)
DK (1) DK1093369T3 (no)
EA (1) EA003142B1 (no)
EE (1) EE04296B1 (no)
ES (1) ES2183583T3 (no)
HU (1) HUP0103922A3 (no)
ID (1) ID27776A (no)
IL (1) IL140603A0 (no)
MY (1) MY117969A (no)
NO (1) NO20010064L (no)
NZ (1) NZ509729A (no)
PL (1) PL195043B1 (no)
PT (1) PT1093369E (no)
RS (1) RS49795B (no)
SK (1) SK284923B6 (no)
TR (1) TR200100146T2 (no)
TW (1) TW592698B (no)
WO (1) WO2000002542A2 (no)
YU (1) YU401A (no)
ZA (1) ZA200100090B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2301899C (en) * 1998-07-27 2008-11-18 Boehringer Ingelheim Pharma Kg Agent with an antidepressant activity
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
US20060281797A1 (en) * 2001-12-11 2006-12-14 University Of Virginia Patent Foundation Neurorestoration with R(+) Pramipexole
EP2305252A1 (en) * 2001-12-11 2011-04-06 University Of Virginia Patent Foundation Use of pramipexole to treat amyotrophic lateral sclerosis
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
CA2554616A1 (en) * 2004-01-22 2005-08-04 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
JP2009504748A (ja) * 2005-08-15 2009-02-05 ユニバーシティ オブ バージニア パテント ファウンデーション Ｒ（＋）プラミペキソールを用いた神経回復
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
KR20090021169A (ko) 2006-05-16 2009-02-27 크놉 뉴로사이언시스 인코포레이티드 Ｒ(+) 및 ｓ(-) 프라미펙솔을 포함하는 조성물 및 이의 사용 방법
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
JP2010521496A (ja) 2007-03-14 2010-06-24 ノップ ニューロサイエンシーズ、インク． キラル精製置換ベンゾチアゾールジアミンの合成
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
US20110190356A1 (en) * 2008-08-19 2011-08-04 Knopp Neurosciences Inc. Compositions and Methods of Using (R)- Pramipexole
ES2459322T3 (es) 2008-09-05 2014-05-09 Supernus Pharmaceuticals, Inc. Método de tratamiento de trastorno de déficit de atención con hiperactividad (TDAH)
CA2760527A1 (en) * 2009-04-30 2010-11-04 Supernus Pharmaceuticals, Inc. Method of treatment of depression
US9512096B2 (en) 2011-12-22 2016-12-06 Knopp Biosciences, LLP Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
MX356727B (es) 2012-02-08 2018-06-12 Supernus Pharmaceuticals Inc Formulaciones de liberacion modificada de viloxacina.
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
ES3043076T3 (en) 2013-07-12 2025-11-24 Areteia Therapeutics Inc Treating elevated levels of eosinophils and/or basophils
EP3038467B1 (en) 2013-08-13 2020-07-29 Knopp Biosciences LLC Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
US9763918B2 (en) 2013-08-13 2017-09-19 Knopp Biosciences Llc Compositions and methods for treating chronic urticaria
IL312486B2 (en) * 2017-04-10 2025-05-01 Chase Therapeutics Corp NK1 antagonist combination and method for treating synucleinopathies
KR20200026920A (ko) 2017-06-30 2020-03-11 체이스 테라퓨틱스 코포레이션 우울증을 치료하기 위한 nk-1 길항제 조성물 및 우울증 치료에 사용하는 방법
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
EP0186087B1 (de) * 1984-12-22 1989-08-23 Dr. Karl Thomae GmbH Tetrahydro-benzthiazole, deren Herstellung und deren Verwendung als Zwischenprodukte oder als Arnzneimittel
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
JP3947582B2 (ja) * 1995-08-15 2007-07-25 中外製薬株式会社 不安神経症治療剤
ES2246058T3 (es) * 1996-03-29 2006-02-01 Pfizer Inc. Derivados bencil(iden)-lactama, su preparacion y su uso como (ant)agonistas selectivos de receptores 5-ht1a y/o 5-ht1d.
CA2273809A1 (en) * 1996-12-02 1998-06-11 Merck Sharp & Dohme Limited Use of nk-1 receptor antagonists for treating movement disorders
CN1293573A (zh) * 1998-01-13 2001-05-02 同步神经元有限责任公司 迟发性运动障碍和其它运动疾病的治疗方法

Also Published As

Publication number Publication date
AR019896A1 (es) 2002-03-20
CA2336833C (en) 2008-09-23
ATE228365T1 (de) 2002-12-15
KR100557692B1 (ko) 2006-03-07
EE200100014A (et) 2002-06-17
BG105112A (bg) 2001-10-31
CN1308533A (zh) 2001-08-15
EA200100084A1 (ru) 2001-08-27
ZA200100090B (en) 2002-04-04
WO2000002542A2 (de) 2000-01-20
EA003142B1 (ru) 2003-02-27
CA2336833A1 (en) 2000-01-20
CZ200177A3 (en) 2001-06-13
DK1093369T3 (da) 2002-12-16
US6255329B1 (en) 2001-07-03
DE59903556D1 (de) 2003-01-09
AU5030399A (en) 2000-02-01
KR20010079491A (ko) 2001-08-22
EP1093369A2 (de) 2001-04-25
BR9911768A (pt) 2001-04-03
SK112001A3 (en) 2001-10-08
YU401A (sh) 2003-10-31
TR200100146T2 (tr) 2001-07-23
JP2002520273A (ja) 2002-07-09
WO2000002542A3 (de) 2000-06-22
NZ509729A (en) 2003-06-30
NO20010064L (no) 2001-03-02
HK1037976A1 (en) 2002-03-01
TW592698B (en) 2004-06-21
CN1230168C (zh) 2005-12-07
ES2183583T3 (es) 2003-03-16
SK284923B6 (sk) 2006-02-02
DE19830201A1 (de) 2000-01-13
HUP0103922A3 (en) 2002-08-28
RS49795B (sr) 2008-06-05
IL140603A0 (en) 2002-02-10
AU762128B2 (en) 2003-06-19
MY117969A (en) 2004-08-30
EP1093369B1 (de) 2002-11-27
PL345842A1 (en) 2002-01-14
PT1093369E (pt) 2003-03-31
CZ294087B6 (cs) 2004-10-13
PL195043B1 (pl) 2007-08-31
HUP0103922A2 (hu) 2002-03-28
BG64972B1 (bg) 2006-11-30
ID27776A (id) 2001-04-26
EE04296B1 (et) 2004-06-15

Similar Documents

Publication Publication Date Title
NO20010064L (no) Midler med en antidepressiv virkning
ID23338A (id) Popok tarik sekali pakai
NO20003640D0 (no) Ny doseringsform
ID26974A (id) Ketoenol siklik arilfenil-tersubstitusi
NO2008014I2 (no) Rotigotin
IS5760A (is) Meðferðarlegar bíarýl afleiður
NO984956D0 (no) Brenner
FI991485A0 (fi) Uusi farmaseuttinen koostumus
ATE284389T1 (de) Zyklische n-acylamin-derivate
NO20005913D0 (no) Legemiddelsammensetning
ID26162A (id) Turunan-turunan benzilbifenil biosida
NO20010046D0 (no) Dolastatin-15-derivater
ID29089A (id) Sediaan farmasi moksifloksasin
ATE236136T1 (de) Benzosulfonderivate
NO20011085D0 (no) Tablett med umiddelbar frigivningsvirkning
DE69919784D1 (de) Spritze
ID23198A (id) Popok tarik sekali pakai
ATE259810T1 (de) Phenyl-xanthinderivate
NO992692L (no) Nefadozon doseringsform
DK1466615T3 (da) Farmaceutisk præparat
DK1056448T3 (da) Farmaceutiske kombinationer med tramadol
NO20000746L (no) Brenner
FR2774599B1 (fr) Cataplasme
DE69921275D1 (de) Inhalationsgerät
ATE233253T1 (de) Chromanderivate

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application